UNILABS NORGE AS
Keywords
x-ray institutesblood banks
Organization
- CEO
- KK
Kjetil Kollstad1973
- Chairman of the board
- AM
- Years since formation
- 26 years
- since Nov 10, 1999
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 278
Ownership
- Number of shares and share classes
- 1
- 1 share class
- Total number of shareholders
- 1
- person
- Belongs to group of
Financials
- Total operating income 2023
- 607,236,924
- NOK
- Annual total result 2023
- 29,309,675
- NOK
- Total equity 2023
- 458,419,452
- NOK
Last update: Jul 14, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
KK 1973 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Board Member | - | |
GE 1969 | Board Member | - |
SB 1985 | Board Member | - |
AM | Alternate Member | - |
HL 1986 | Board Member | - |
AM | Chairman | - |
| Board Member | - | |
KK 1973 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Last update: Mar 3, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1 | 100 % |
Shares owned by the UNILABS NORGE AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 358 | 100 % | |
| Ordinary shares | 84 | 0.24 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2023: NOK 607,236,924Operating profit 2023: NOK 64,360,250Employees: 278
Financials
in NOK
Summary
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 607,236,924 | 602,395,513 | 578,307,820 |
Annual Total Result | 29,309,675 | 30,102,173 | 44,853,387 |
Total assets | 1,206,458,774 | 1,187,297,007 | 1,193,450,988 |
Total liabilities | 748,039,322 | 758,069,133 | 794,168,668 |
Total equity | 458,419,452 | 429,227,874 | 399,282,320 |
P&L
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 607,236,924 | 602,395,513 | 578,307,820 |
Total operating costs | 542,876,675 | 532,969,511 | 487,311,423 |
Operating result | 64,360,250 | 69,426,003 | 90,996,397 |
Financial income/costs | -26,919,016 | -31,031,604 | -32,762,160 |
Profit before tax | 37,441,233 | 38,394,398 | 58,234,238 |
Total tax & extraordinary income/cost | 8,131,558 | 8,292,225 | 13,380,851 |
Annual Total Result | 29,309,675 | 30,102,173 | 44,853,387 |
Balance overview
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total fixed assets | 809,189,927 | 820,810,411 | 862,049,507 |
Total current assets | 397,268,847 | 366,486,597 | 331,401,481 |
Total assets | 1,206,458,774 | 1,187,297,007 | 1,193,450,988 |
Short term debt | 153,662,393 | 175,581,026 | 168,355,539 |
Long term debt | 594,376,929 | 582,488,107 | 625,813,129 |
Total liabilities | 748,039,322 | 758,069,133 | 794,168,668 |
Contributed capital | 381,825,441 | 381,825,441 | 381,825,441 |
Retained earnings | 76,594,011 | 47,402,433 | 17,456,879 |
Total equity | 458,419,452 | 429,227,874 | 399,282,320 |
Total equity and liabilities | 1,206,458,774 | 1,187,297,007 | 1,193,450,988 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.906
Industrial group
Medical laboratories